Zymeworks Inc.

NASDAQ: ZYME
Share price (3/28/25): $12.37
Market cap (3/28/25): $861 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Nodelman Oleg, EcoR1 Capital, LLC

Nodelman Oleg, EcoR1 Capital, LLC

Nodelman Oleg, EcoR1 Capital, LLC

EcoR1 Capital, LLC

Nodelman Oleg, EcoR1 Capital, LLC

News Filter

Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Announces Appointment of Oleg Nodelman to Board of Directors

Outlines Strategic Priorities and Outlook for 2025 and 2026

Shareholder Vote Results, Other Events

FDA Grants U.S. Approval of Ziihera® (Zanidatamab-Hrii) for the Treatment of Adults With Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness